+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium



Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium



Artificial Organs 28(2): 234-237



Ozonated autohemotherapy (O3-AHT) is used in the treatment of atherosclerotic ischemia of lower limbs (AILL). The impact of ozone on serum lipids and endothelium injury is of particular interest since these factors are important in the development of atherosclerotic lesions. To evaluate this issue, a prospective, placebo-controlled study was designed. Twelve hemodialyzed subjects with AILL received autohemotherapy with oxygen as a control followed by O3-AHT with ozone concentration of 50 micro g/ml. Serum lipids and plasma activity of von Willebrand factor (vWF) were measured. After O3-AHT, total cholesterol significantly decreased compared to the baseline (-8.34%) [P < 0.01]. LDL cholesterol was also significantly lower than the initial value (-17.71%) [P < 0.001]. No significant changes in the activity of vWF were found after the first session of O3-AHT and after all nine sessions of O3-AHT. The study demonstrated that O3-AHT did not affect deleteriously the endothelium in patients with chronic renal failure on maintenance hemodialysis. It may stimulate beneficial changes in serum lipid profile manifesting as a decrease in the total- and LDL-cholesterol levels.

(PDF emailed within 0-6 h: $19.90)

Accession: 049839608

Download citation: RISBibTeXText

PMID: 14961966

DOI: 10.1111/j.1525-1594.2003.47211.x


Related references

Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis. Archives of Medical Research 37(8): 1034-1037, 2006

The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs. International Journal of Artificial Organs 26(4): 297-303, 2003

Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients. Nihon Jinzo Gakkai Shi 41(1): 1-7, 1999

Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy. International Journal of Artificial Organs 27(9): 766-771, 2004

Pattern of lipid profile in patients on maintenance hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 21(3): 565-570, 2010

Hemodialysis membranes influence the lipid profile of patients on chronic hemodialysis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 307A, 2000

Can dialysis membrane improve serum lipid profile in maintenance hemodialysis patients?. Nephrology Dialysis Transplantation 12(9): A129, 1997

Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients. Blood Purification 26(4): 322-332, 2008

No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients. Mediators of Inflammation 13(5-6): 377-380, 2005

Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy. Iranian Journal of Kidney Diseases 5(2): 114-118, 2011

Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients. Open Access Rheumatology 9: 159-165, 2017

Does erythropoietin treatment influence the lipid status of patients on maintenance hemodialysis?. Polskie Archiwum Medycyny Wewnetrznej 94(5): 410-417, 1995

Beneficial effects of ozonated autohemotherapy in hemodialyzed patients with atherosclerotic ischemia of lower limbs. Nephrology Dialysis Transplantation 17(Abstracts Supplement 1): 260, 2002

Efficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study. Experimental and Therapeutic Medicine 8(5): 1423-1427, 2014

Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study. International Journal of Artificial Organs 27(1): 29-34, 2004